Herombopag + rhTPO in Severe Immune Thrombocytopenia

NCT05328804 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: rhTPO
DRUG: Herombopag

Sponsor

Yin Jie